Big Pharma Q1 earnings roundup: AstraZeneca, BMS, Merck, Sanofi

5d ago, source: MM&M

A group of prominent pharma companies unveiled their respective earnings Thursday morning, with some soaring and others ...

Global Eisenmenger Complex Management Industry

1d ago, source: Future Market Insights

Global Eisenmenger Complex Management Industry is expected to reach US$ 12.9 Billion at a CAGR of 5.3% by 2033 | FMI Reveals ...

Merck raises guidance as Keytruda sales jump 20% in Q1

on MSN ago, source:

Merck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer ...

Pharma's reputation falls for first time since 2018 as pandemic-era halo slips

2d ago, source: FiercePharma

Pharma’s pandemic-era halo is slipping. After tracking a surge in the industry’s reputation, PatientView found patient groups ...

Ono Pharmaceutical to acquire Deciphera Pharma, maker of cancer drugs, for $2.4 billion

2d ago, source: STAT

Ono Pharmaceutical of Japan said Monday it will acquire Deciphera Pharmaceuticals, a Boston-based maker of cancer drugs, for ...

Richmond pharma company lands federal contract for nerve-agent antidote

8d ago, source: The Business Journals

Richmond pharmaceutical company Kaléo Inc. has been tapped by federal agencies to develop a countermeasure to nerve-agent ...

Japan’s Ono Pharma says $2.4 billion Deciphera purchase ‘first step’ for global expansion

1d ago, source: KELO

Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets. WHY IT'S IMPORTANT With this deal, Ono ...

DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with Losses to Contact the Firm

1d ago, source: Business Insider

LOS ANGELES, CA / ACCESSWIRE / April 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Akero Therapeutics, Inc. ("Akero ...

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc. with Losses to Contact the Firm

21h ago, source: Business Insider

Los Angeles, California--(Newsfile Corp. - April 30, 2024) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Akero Therapeutics, ...